Elevance Extends Losses as BofA Cuts on Medicaid Headwinds
Centene Analyst Ratings
Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), Centene (CNC) and Radnet (RDNT)
Jefferies Adjusts Price Target on Centene to $83 From $90
The Latest Analyst Ratings For Centene
Centene Analyst Ratings
JPMorgan Adjusts Price Target on Centene to $80 From $85
Centene (CNC) Gets a Buy From Barclays
Barclays Adjusts Price Target on Centene to $90 From $104, Maintains Overweight Rating
Navigating 11 Analyst Ratings For Centene
Centene Analyst Ratings
Centene Analyst Ratings
Stephens Adjusts Price Target on Centene to $77 From $83
Centene Analyst Ratings
What 11 Analyst Ratings Have To Say About Centene
Oppenheimer Remains a Buy on Centene (CNC)
Analysts Offer Insights on Healthcare Companies: Centene (CNC), Zimmer Biomet Holdings (ZBH) and Madrigal Pharmaceuticals (MDGL)
Centene Analyst Ratings
Baird Initiates Coverage On Centene With Neutral Rating, Announces Price Target of $83
Centene Analyst Ratings